About Bryant Godfrey

Bryant Godfrey is a partner at Foley Hoag who provides strategic regulatory advice to pharmaceutical, medical device and biotech companies, helping them to navigate challenges relating to the development, manufacturing, approval and promotion of drugs, biologics, medical devices, and combination products. Having spent nearly a decade at the US Food and Drug Administration in senior regulatory and policy roles, including as the head lawyer of the FDA’s Office of Prescription Drug Promotion, his experience encompasses a wide range of issues relating to advertising and promotion, scientific exchange, investigations of off-label marketing, product jurisdiction, medical product development and approval/clearance, labelling, and post-marketing commitments and requirements, among others.